Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS4869

Imatinib mesylate effect on bone marrow hematopoietic cells of chronic myeloid leukemia patients

Analysis of bone marrow hematopoietic cells in chronic myeloid leukemia (CML) patients one month after imatinib mesylate (IM) therapy. CML is caused by expression of the BCR/ABL fusion oncogene. Results provide insight into the molecular consequences of IM blockade of oncoprotein Bcr-Abl in CML.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 10 age, 10 gender, 10 individual, 3 protocol sets
Platform:
GPL570
Series:
GSE33075
27 Samples
Download data: CEL
DataSet
Accession:
GDS4869
ID:
4869

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center